Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Bath & Body Works, Inc. regarding a class action lawsuit alleging misleading statements and failure to disclose critical information during a specified class period [1]. Group 1: Allegations - The complaint alleges that Bath & Body Works' strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected growth in net sales [1]. - It is claimed that as the aforementioned strategy faltered, the company relied on brand collaborations to mask weak underlying financial results [1]. - The lawsuit suggests that the company was unlikely to meet its previously issued financial guidance due to these issues, rendering positive statements about its business and prospects materially misleading [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as June 4, 2024, to November 9, 2025, and shareholders are encouraged to register for participation [1][2]. - The deadline for shareholders to seek lead plaintiff status is March 13, 2026, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3].

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Bath & Body Works, Inc. (NYSE: BBWI). Shareholders who purchased shares of BBWI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/bath-body-works-inc-loss-submission-form/?id=183254&from=3  CLASS PERIOD: Ju ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was driving topline growth through category adjacencies [5]. Group 3: Stock Performance and Financial Results - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bath & Body Works, Inc. (NYSE: BBWI) between June 4, 2024 and November 19, 2025, both dates inclusive (the “Class Period”), of the important March 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Bath & Body Works securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ar ...

NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Bath & Body Works, Inc. ("Bath & Body Works, Inc." or the "Company") (NYSE: BBWI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Bath & Body Works, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and November 9, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, leading to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 per share [6]. - On November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 per share [7]. Legal Context - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Bath & Body Works securities, with a deadline of March 16, 2026, for investors to seek lead plaintiff status [3].

New York, New York--(Newsfile Corp. - January 27, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Bath & Body Works, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/case ...

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (NYSE: BBWI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Bath & Body Works Class Action Lawsuit? Do you, or did you, own shares of Bath & Body Works, Inc. (NYSE: BBWI)?Did you purchase your shares between June 4, 2024 and November 19 ...

Core Insights - Graphene Investments has completely liquidated its position in Bath & Body Works, selling 114,700 shares for an estimated $2.95 million, indicating a significant loss of confidence in the company's turnaround prospects [2][3][9] Company Overview - Bath & Body Works reported a total revenue of $7.35 billion and a net income of $699 million for the trailing twelve months (TTM) [5] - The company has a dividend yield of 3.74% and its share price was $21.45 as of January 26, 2026 [5] Transaction Details - The sale of 114,700 shares resulted in a decrease in the position's end-of-quarter value by $2.95 million, reflecting both the sale and price changes [3][7] - This transaction accounted for 1.85% of Graphene Investments' 13F reportable assets under management (AUM) [7] - Post-sale, Graphene Investments holds zero shares of Bath & Body Works, which previously represented 1.9% of its AUM [7][8] Market Performance - As of January 26, 2026, Bath & Body Works shares have decreased by 39.5% over the past year, underperforming the S&P 500 by 54.05 percentage points [8] Implications for Investors - The complete exit from Bath & Body Works by Graphene Investments suggests a fundamental change in the investment thesis rather than routine portfolio rebalancing, especially following a 25% drop in stock price after disappointing third-quarter results [9] Company Profile - Bath & Body Works offers a range of products including home fragrance, body care, soaps, and sanitizers, primarily through direct-to-consumer sales in North America, with additional revenue from international franchises and wholesale arrangements [10] - The company targets a broad consumer base in the United States and Canada seeking personal care and home fragrance products [10]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Bath & Body Works, Inc. due to allegations of misleading statements and failure to disclose critical information regarding the company's financial performance and business strategy [2][5]. Financial Performance - Bath & Body Works reported a 1% year-over-year decline in revenue for Q3 2025, missing prior guidance of 1-3% growth [6]. - The company's net income dropped by 26% to $77 million [6]. - The full-year earnings per diluted share outlook was sharply reduced from a range of $3.28 to $3.53 to "at least $2.83" [6]. Business Strategy - The company's strategy of pursuing "adjacencies, collaborations and promotions" was found to be ineffective in growing the customer base and delivering expected sales growth [5]. - Bath & Body Works admitted that this strategy led to reduced investment in core categories and an overreliance on brand collaborations to mask weak financial results [6]. Stock Market Reaction - Following the disappointing financial disclosures, Bath & Body Works' stock price fell by $5.22, or 24.8%, closing at $15.82 per share on November 20, 2025 [7].